ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633271; 2) Community: the network communities that were significantly associated with the response to NSC 633271; 3) Molecule: the relationships between components within communities and NSC 633271; 4) MDR: the compounds that were significantly associated with the NSC 633271.

NSC Compound Enrichment Correlation
NSC 697535 Null 0.0321614375606959 0.066010465
NSC 710326 Null 0.0321614375606959 -0.00094380149
NSC 715407 Null 0.0321614375606959 0.45406936
NSC 718781 Erlotinib hydrochloride 0.0321614375606959 -0.26488862
NSC 722996 2-(4-chloro-benzyl)-1H-naphth[2,3-d]imidazole 0.0321614375606959 -0.097172718
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0321614375606959 0.45354201
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0321614375606959 0.3796825
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0321614375606959 0.3674486
NSC 756483 SB-742864 0.0321614375606959 0.31928231
NSC 92207 Null 0.0321614375606959 0.1525962
Total:75  Current:51    [First] [Prev] [Next] [Last]